Trial intelligence / Profile preview

Daptomycin vs Vancomycin for Diabetic Foot Infections

NCT01133600Phase 4Terminated

Sponsor
The Clinical Alliance for Research and Education - Infectious Diseases
Start
Aug 2010
Primary completion
Aug 2012
Modality
Cyclic Peptides, Antimicrobial Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of daptomycin in diabetic foot infection (DFI), sponsored by The Clinical Alliance for Research and Education - Infectious Diseases. Started Aug 2010; status: terminated.

02

Drugs

daptomycin
03

Conditions

diabetic foot infection (DFI)

Beyond the preview

Go deeper on NCT01133600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01133600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call